Aurobindo Pharma Ltd, through its wholly owned subsidiary Apitoria Pharma Pvt Ltd, will acquire an 80% stake in the Contract Research Services business of A1 Biochem Group. The acquisition will be completed within 90 to 120 days for cash consideration at an enterprise value of $17 million on a debt-free and cash-free basis. Building CRDMO […]